Sponsor Pipeline

Shanghai Cancer Hospital, China Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
3
Recruiting
1
Phase 3
2
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 2
1
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT05800223 Armatinib Alone or in Combination With SRT for Brain Metastases EGFR-mutated Non-small… Non-small Cell Lung Cancer Metastatic Recruiting
Phase 2
NCT06901817 A Study of the Safety and Efficacy of Pemetrexed Combined with Nivolumab Via… Leptomeningeal Metastasis Recruiting
Not specified
NCT04522687 Influence of Radiotherapy and Chemotherapy in the Value of Peripheral Blood Lymphocyte… NSCLC Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (1)
Get alerts when Shanghai Cancer Hospital, China's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free